New Agility MLC expected to attract many ESTRO attendees to Elekta exhibit

BARCELONA /PRNewswire/ -- ESTRO Booth #200 -- At the 2012 European Society for Therapeutic Radiology and Oncology (ESTRO) exhibition, 9-13 May at the Centro de Convenciones Internacional de Barcelona, Elekta will demonstrate the richness of its spectrum of radiation oncology solutions with the Elekta Cancer Care Clinic. The clinic is the patient's or doctor's view of the comprehensive, well-integrated radiotherapy department, showcasing Elekta's entire portfolio.

The Elekta Cancer Care Clinic will feature a floor plan that includes replicas of a reception area, pre-treatment and simulation rooms, doctor's office, treatment planning and physics rooms, and a treatment delivery suite. Within each area will be arrayed Elekta solutions, encompassing Leksell Gamma Knife® Perfexion™ stereotactic radiosurgery, linac-based radiotherapy, brachytherapy, MOSAIQ® Oncology Information System, treatment planning solutions and much more. The primary theme for the 2012 ESTRO exhibit is "Experience the Elekta Difference."
"Our secondary theme is 'With You All the Way,' which conveys to our customers and prospective customers that Elekta is their single partner who can provide them with complete, integrated solutions for their clinical practice," says Olof Sanden, Elekta's Executive Vice President, Europe and AFLAME. "This theme also communicates that we can offer customers tailored and personalized solutions regardless of whether they're just starting a practice or need to expand."

New Agility MLC and brachytherapy solutions
To be prominently highlighted in the Elekta exhibit will be Agility™*, Elekta's revolutionary new 160-leaf MLC, featuring leaf speeds of up to 6.5 cm per second -- twice as fast as the leaf speeds of other MLCs commonly used in the industry. The Agility high resolution MLC will enable clinicians to further exploit the benefits of advanced techniques such as SRT and VMAT. Agility also features an extremely low leakage design -- considerably lower leakage than other commercial MLCs. Elekta strongly believes patients and clinics will benefit from the speed and reliability of this new MLC design.

In March 2012, Elekta announced it had achieved CE Marking for Agility, enabling medical centers across Europe and other regions to adopt the technology.

Brachytherapy solutions also will be highly visible in the Elekta exhibit during ESTRO 31, as well as Booth #50 at The World Congress of Brachytherapy, convening 10-12 May. In September 2011, Elekta completed the acquisition of Nucletron, the world leader in brachytherapy. Now, in addition to providing proven solutions that employ external beam radiation, Elekta also offers a world class therapy that treats cancer from the "inside out."

More HCB News